Posted on 9/10/20
MEDNAX To Sell MEDNAX Radiology Solutions To Radiology Partners For $885M
MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, today announced a definitive agreement pursuant to which Radiology Partners
Posted on 9/10/20
Is Pfizer the Best Way to Play the Coronavirus Vaccine Race?
Nucleic acid vaccines, which are either DNA- or RNA-based, hold significant promise in the fight against COVID-19. Pharma giant Pfizer (NYSE:PFE) and clinical-stage Moderna (NASDAQ:MRNA) are . . .
Posted on 9/10/20
Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) moved one step closer to potentially selling doses of their coronavirus vaccine, BNT162b2, to EU member states. Investors have known since . . .
Posted on 9/10/20
Seelos Therapeutics Closes $7M Registered Direct Offering
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it has closed its previously announced registered direct offering to certain institutional investors of . . .
Posted on 9/9/20
Feinstein Institutes Receives $1.7M Grant
MANHASSET, N.Y.--(BUSINESS WIRE)--Only half of the adults in the United States get the exercise they need to help reduce and prevent chronic diseases. To better understand . . .
Posted on 9/9/20
Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million
PARSIPPANY, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today reported preliminary unaudited . . .
Posted on 9/8/20
Ambu Awarded Contract with UroGPO for Single-Use Cystoscope
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract with UroGPO, the largest Group Purchasing Organization for urology . . .
Posted on 9/8/20
Gardner Standard Partners with Wisconsin Pharmacal Company
Gardner Standard LLC is pleased to announce its investment in Wisconsin Pharmacal Company, LLC and its wholly-owned subsidiary Lake Consumer Products, Inc. a leading manufacturer and . . .
Posted on 9/8/20
Feinstein Institutes Receives $1.7M NIH Grant
MANHASSET, N.Y.--(BUSINESS WIRE)--To research new treatments for Hereditary hemorrhagic telangiectasia (HHT) – a genetic bleeding disorder in which blood vessels do not form properly– the National . . .
Posted on 9/8/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political Pressure
With the U.S. presidential election scheduled around the same time that the first coronavirus vaccines will be up for potential authorization or approval by the Food . . .
Posted on 9/8/20
Johnson & Johnson Aiming to Enroll One-Third of Phase 3 Trial Patients From Latin America
Johnson & Johnson (NYSE:JNJ) is looking south of the U.S. border for participants in a phase 3 clinical trial of its coronavirus vaccine candidate. The company . . .
Posted on 9/8/20
Is Vertex Pharmaceuticals Stock a Buy?
A tumultuous 2020 has revealed the strengths and weaknesses of companies across the stock market spectrum. While many businesses have struggled to adjust to pandemic highs . . .
Posted on 9/5/20
Royalty Pharma Closes $6B Senior Unsecured Notes
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has closed an offering of $6 billion senior unsecured . . .
Posted on 9/4/20
Seelos Therapeutics Pricing of $7.0 Million Registered Direct Offering
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for . . .
Posted on 9/4/20
Better Coronavirus Stock: AstraZeneca or Johnson & Johnson?
Investors have trained their eyes on many biotech companies this year, with a particular focus on those that have a horse in the coronavirus vaccine race. . . .
Posted on 9/4/20
Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October
Albert Bourla, the CEO of Pfizer (NYSE:PFE), raised a lot of eyebrows on Thursday morning during a press briefing with biopharmaceutical industry executives leading efforts to . . .
Posted on 9/4/20
Johnson & Johnson Coronavirus Vaccine Candidate Shows Encouraging Results in Animal Trial
Johnson & Johnson (NYSE:JNJ), one of many companies vying to be fast to market with a coronavirus vaccine, published encouraging results for its candidate on Thursday. . . .
Posted on 9/3/20
PRA Health Sciences Partnership with The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a first-of-its-kind global master clinical trial to develop . . .
Posted on 9/3/20
Northwell Labs Invests $30M
LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--Despite low positivity rates and prudent public action to prevent a recurrence of coronavirus disease 2019 (COVID-19) in New York State, Northwell Health . . .
Posted on 9/3/20
Why These 3 Coronavirus Stocks Are Falling This Week
Shares of COVID-19 vaccine developers Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX), and Pfizer (NYSE:PFE) have fallen this week after presentations to the Centers for Disease Control (CDC) revealed . . .
Posted on 9/3/20
Pfizer Has Been a Mediocre Stock at Best. Here's Why You Should Consider Buying It Anyway
The booming stock market recently hit an all-time high. Many stocks regained all of their losses from earlier in the year and skyrocketed a lot higher. . . .
Posted on 9/2/20
JMD Properties Acquires Diagnostic Oncology Company
NEW YORK--(BUSINESS WIRE)--JMD Properties, Inc. (OTC: JMDP) today announced it has acquired Stella Diagnostics, LLC, in a preferred stock acquisition and will be changing its name . . .
Posted on 9/2/20
Celsion Corp. Restructures its Strategic Loan Facility
Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that on August 28, 2020 it entered into an amendment to its existing $10 million . . .
Posted on 9/2/20
Forget Johnson & Johnson, AbbVie Is a Better Dividend Stock
Dividend stocks are great for long-term investors who want to sit back and watch secondary income accumulate. Dividend investing can be a great way to supplement . . .
Posted on 9/1/20
CityMD Acquires Urgent Care Now
CityMD, the leading urgent care provider in the New York metropolitan area, today announced the acquisition of Urgent Care Now, a leading urgent care provider in . . .
New York
